Congress Park Capital »

SPDR S&P Biotech shares owned by Congress Park Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Congress Park Capital from 13F filings

Historical chart of Congress Park Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Congress Park Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Congress Park Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $596k 4.9k 121.93

More positions owned by Congress Park Capital

Ishares Tr Core S&p500 Etf (IVV)
Nuveen Floating Rate Income Fund (JFR)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Ultra Short Dur (ICSH)
Amazon (AMZN)
Virtus Convertible & Income Com New (NCV)
Nuveen Insured Tax-Free Adv Munici (NEA)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Apple (AAPL)
MercadoLibre (MELI)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Nuveen Div. Advantage Muni. Fund (NAD)

View all positions for Congress Park Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech